The Oncosearch | Oncotarget

WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer Research Paper

Annalucia Serafino, Noemi Moroni, Manuela Zonfrillo, Federica Andreola, Luana Mercuri, Giuseppe Nicotera, Joseph Nunziata, Riccardo Ricci, Armando Antinori, Guido Rasi, Pasquale Pierimarchi

Published Jan 11, 2014 · Vol. 5, No. 4 · pp. 978-992

Keywords: Wnt/Î²-catenin pathway, Colorectal carcinogenesis, Inflammatory Bowel Disease, Diagnostic/therapeutic biomarkers, Multiparametric analysis

Alternative splicing of FBP-interacting repressor coordinates c-Myc, P27Kip1/cyclinE and Ku86/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway Research Paper

Bahityar Rahmutulla, Kazuyuki Matsushita, Mamoru Satoh, Masanori Seimiya, Sachio Tsuchida, Shuji Kubo, Hideaki Shimada, Masayuki Ohtsuka, Masaru Miyazaki, Fumio Nomura

Published Dec 21, 2013 · Vol. 5, No. 9 · pp. 2404-2417

Keywords: FBP interacting repressor (FIR), bleomycin, DNA damage, Ku86, c-Myc, P27Kip1

MYC and MiR: vicious circle Editorial Materials

Xiaohong Zhao, Xinwei Zhang, Jianguo Tao

Published Nov 28, 2013 · Vol. 4, No. 12 · pp. 2168-2169

Keywords: miRNA, microenvirenment

Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer. Research Paper

Anastasia Wyce, Yan Degenhardt, Yuchen Bai, BaoChau Le, Susan Korenchuk, Ming-Chih Crouthamel, Charles McHugh, Robert Vessella, Caretha Creasy, Peter Tummino, Olena Barbash

Published Nov 23, 2013 · Vol. 4, No. 12 · pp. 2419-2429

Keywords: BET inhibitor, prostate cancer, c-Myc

FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma Research Paper

Dan Li, Hong Mei, Meng Qi, Dehua Yang, Xiang Zhao, Xuan Xiang, Jiarui Pu, Kai Huang, Liduan Zheng, Qiangsong Tong

Published Nov 5, 2013 · Vol. 4, No. 11 · pp. 2021-2044

Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma Research Paper

Jennifer K Wolter, Nikolaus E Wolter, Alvaro Blanch, Teresa Partridge, Lynn Cheng, Daniel A. Morgenstern, Monika Podkowa, David R. Kaplan, Meredith S. Irwin

Published Nov 4, 2013 · Vol. 5, No. 1 · pp. 161-172

Keywords: neuroblastoma, propranolol, beta-adrenergic receptor, p53, p73

BET bromodomain protein inhibition is a therapeutic option for medulloblastoma Research Paper

Anton George Henssen, Theresa Thor, Andrea Odersky, Lukas Heukamp, Nicolai El-Hindy, Anneleen Beckers, Frank Slpeleman, Kristina Althoff, Simon SchÃ¤fers, Alexander Schramm, Ulrich Sure, Gudrun Fleischhack, Angelika Eggert, Johannes Hubertus Schulte

Published Oct 27, 2013 · Vol. 4, No. 11 · pp. 2080-2095

Keywords: BET bromodomains, BRD4, MYC, JQ1, pediatric brain tumors, targeted therapy

MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia Research Paper

Annalisa Astolfi, Francesca Vendemini, Milena Urbini, Fraia Melchionda, Riccardo Masetti, Monica Franzoni, Virginia Libri, Salvatore Serravalle, Marco Togni, Giuseppina Paone, Luca Montemurro, Daniela Bressanin, Francesca Chiarini, Alberto M Martelli, Roberto Tonelli, Andrea Pession

Published Sep 29, 2013 · Vol. 5, No. 1 · pp. 120-130

Keywords: pediatric T-ALL, MYCN, peptide nucleic acid, TAL1

Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5 Research Paper

Huabo Wang, Jay Chauhan, Angela Hu, Kelsey Pendleton, Jeremy L. Yap, Philip E. Sabato, Jace W. Jones, Mariarita Perri, Jianshi Yu, Erika Cione, Maureen A. Kane, Steven Fletcher, Edward V. Prochownik

Published Jun 22, 2013 · Vol. 4, No. 6 · pp. 936-949

Keywords: 10058-F4, 10074-G5, intrinsically disordered proteins, JQ-1, BRD4

Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations Research Paper

Jonathan M. Gerber, Jessica L. Gucwa, David Esopi, Meltem Gurel, Michael C. Haffner, Milada Vala, William G. Nelson, Richard J. Jones, Srinivasan Yegnasubramanian

Published May 6, 2013 · Vol. 4, No. 5 · pp. 715-728

Keywords: chronic myeloid leukemia, CML, leukemic stem cell, LSC, normal hematopoietic stem cell, HSC, myeloid progenitor cells, CD34, CD38, ALDH, IL2RA, CD25, DPP4, CD26, GAS2

Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo Research Paper

Shuang Yan, Zhijie Li, Carol J Thiele

Published Mar 19, 2013 · Vol. 4, No. 3 · pp. 433-445

Keywords: neuroblastoma, Ewing sarcoma, rhabdomyosarcoma, JAK inhibitor, STAT3

Intraductal Delivery of Adenoviruses Targets Pancreatic Tumors in Transgenic Ela-myc Mice and Orthotopic Xenografts Research Paper

Anabel JosÃ©, Luciano Sobrevals, Juan Miguel Camacho-SÃ¡nchez, Meritxell Huch, NÃºria Andreu, Eduard Ayuso, Pilar Navarro, Ramon Alemany, Cristina Fillat

Published Jan 12, 2013 · Vol. 4, No. 1 · pp. 94-105

Keywords: Pancreatic cancer, adenovirus, orthotopic xenografts, transgenic mice, thymidine kinase

FAK is a critical regulator of neuroblastoma liver metastasis Research Paper

Sora Lee, Jingbo Qiao, Pritha Paul, Kathleen L. Oâ€™Connor, Mark Evers, Dai H. Chung

Published Nov 16, 2012 · Vol. 3, No. 12 · pp. 1576-1587

Keywords: GRP-R, FAK, malignant transformation, metastasis, neuroblastoma

miR-150: targeting MLL leukemia Editorial

Xi Jiang, Jianjun Chen

Published Nov 14, 2012 · Vol. 3, No. 11 · pp. 1268-1269

Keywords: miR-150, MLL leukemia, FLT3, MYC, MYB, signaling, therapy

Epigenetics, c-Myc and Aggressive B-cell Lymphomas Editorial

Yizhuo Zhang, Xiaohong Zhao, Jianguo Tao

Published Nov 13, 2012 · Vol. 3, No. 11 · pp. 1264-1265

Keywords: myc, Epigenetics, lymphoma

Burkitt lymphomagenesis linked to MYC plus PI3K in germinal center B cells Editorial

Sandrine Sander, Klaus Rajewsky

Published Oct 28, 2012 · Vol. 3, No. 10 · pp. 1066-1067

Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer Research Paper

Lydia Kriegl, Michael Vieth, Thomas Kirchner, Antje Menssen

Published Oct 3, 2012 · Vol. 3, No. 10 · pp. 1182-1193

Keywords: Serrated route, colorectal cancer, SIRT1, c-MYC, BRAF and KRAS mutation, wnt signalling

FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration Research Paper

VÃ©ronique Frattini, Federica Pisati, Maria Carmela Speranza, Pietro Luigi Poliani, Gianmaria FrigÃ©, Gabriele Cantini, Dimos Kapetis, Manuela Cominelli, Alessandra Rossi, Gaetano Finocchiaro, Serena Pellegatta

Published Sep 22, 2012 · Vol. 3, No. 10 · pp. 1146-1157

Keywords: FOXP3, glioblastoma, neurospheres, proliferation, migration

Oncogene addiction to c-MYC in myeloma cells Editorial

Toril Holien, Anders Sundan

Published Aug 25, 2012 · Vol. 3, No. 8 · pp. 739-740

Keywords: MYC, myeloma, oncogene

Sox9 is required for prostate development and prostate cancer initiation Research Paper

Zhenhua Huang, Paula J. Hurley, Brian W. Simons, Luigi Marchionni, David M. Berman, Ashley E. Ross, Edward M. Schaeffer

Published Jul 2, 2012 · Vol. 3, No. 6 · pp. 651-663

Keywords: Sox9, prostate, development, cancer, initiation

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer Research Paper

Alternative splicing of FBP-interacting repressor coordinates c-Myc, P27Kip1/cyclinE and Ku86/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway Research Paper

MYC and MiR: vicious circle Editorial Materials

Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer. Research Paper

FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma Research Paper

Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma Research Paper

BET bromodomain protein inhibition is a therapeutic option for medulloblastoma Research Paper

MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia Research Paper

Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5 Research Paper

Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations Research Paper

Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo Research Paper

Intraductal Delivery of Adenoviruses Targets Pancreatic Tumors in Transgenic Ela-myc Mice and Orthotopic Xenografts Research Paper

FAK is a critical regulator of neuroblastoma liver metastasis Research Paper

miR-150: targeting MLL leukemia Editorial

Epigenetics, c-Myc and Aggressive B-cell Lymphomas Editorial

Burkitt lymphomagenesis linked to MYC plus PI3K in germinal center B cells Editorial

Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer Research Paper

FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration Research Paper

Oncogene addiction to c-MYC in myeloma cells Editorial

Sox9 is required for prostate development and prostate cancer initiation Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer Research Paper

Alternative splicing of FBP-interacting repressor coordinates c-Myc, P27Kip1/cyclinE and Ku86/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway Research Paper

MYC and MiR: vicious circle Editorial Materials

Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer. Research Paper

FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma Research Paper

Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma Research Paper

BET bromodomain protein inhibition is a therapeutic option for medulloblastoma Research Paper

MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia Research Paper

Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5 Research Paper

Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations Research Paper

Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo Research Paper

Intraductal Delivery of Adenoviruses Targets Pancreatic Tumors in Transgenic Ela-myc Mice and Orthotopic Xenografts Research Paper

FAK is a critical regulator of neuroblastoma liver metastasis Research Paper

miR-150: targeting MLL leukemia Editorial

Epigenetics, c-Myc and Aggressive B-cell Lymphomas Editorial

Burkitt lymphomagenesis linked to MYC plus PI3K in germinal center B cells Editorial

Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer Research Paper

FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration Research Paper

Oncogene addiction to c-MYC in myeloma cells Editorial

Sox9 is required for prostate development and prostate cancer initiation Research Paper